{
    "Trade/Device Name(s)": [
        "MAGLUMI 2000 FT4"
    ],
    "Submitter Information": "Shenzhen New Industries Biomedical Engineering Co., Ltd.",
    "510(k) Number": "K182423",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080167"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC"
    ],
    "Summary Letter Date": "October 4, 2018",
    "Summary Letter Received Date": "September 6, 2018",
    "Submission Date": "August 31, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1695"
    ],
    "Regulation Name(s)": [
        "Free Thyroxine Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free thyroxine (FT4)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MAGLUMI 2000"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for MAGLUMI 2000 FT4 chemiluminescence immunoassay for quantitative determination of free thyroxine in human serum",
    "Indications for Use Summary": "For in vitro diagnostic quantitative determination of free thyroxine (FT4) in human serum, used in the diagnosis of thyroid disorders",
    "fda_folder": "Clinical Chemistry"
}